Arie Weinstock

Research activity per year

Fingerprint

Dive into the research topics where Arie Weinstock is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

GW EPiCog Study: An Open-label Exploratory Investigation of Cognitive Outcomes with Cannabidiol Oral Solution (EPIDlOLEX; GWP42003-P) (EPl-COG)
Weinstock, A. (PI)
Syneos Health LLC
01/15/20 → 01/15/22
University at Buffalo
Project: Research
An Open Label extension study to investigate the safety of cannabidiol (GWP42002-P; CPD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes
Weinstock, A. (PI)
GW Research Limited
09/4/15 → 09/3/20
University at Buffalo
Project: Research
A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome
Weinstock, A. (PI)
GW Research Limited
05/5/15 → 05/4/17
University at Buffalo
Project: Research
Expanded access IND study
Weinstock, A. (PI)
NYS Department of Health
04/1/15 → 03/31/19
University at Buffalo
Project: Research
A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in children and adults
Weinstock, A. (PI)
GW Research Limited
03/31/15 → 03/30/17
University at Buffalo
Project: Research

33 Article
2 Review article
1 Comment/debate

Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program
Weinstock, A., Bebin, E. M., Checketts, D., Clark, G. D., Szaflarski, J. P., Seltzer, L. E., Thiele, E. A. & Sahebkar, F., Oct 2024, In: Epilepsia Open. 9, 5, p. 1816-1825 10 p.
University at Buffalo
Research output: Contribution to journal › Article › peer-review

Open Access
6 Scopus citations
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program
Flamini, R. J., Comi, A. M., Bebin, E. M., Chez, M. G., Clark, G., Devinsky, O., Hussain, S. A., Lyons, P. D., Patel, A. D., Rosengard, J. L., Sahebkar, F., Segal, E., Seltzer, L., Szaflarski, J. P. & Weinstock, A., Aug 2023, In: Epilepsia. 64, 8, p. e156-e163
University at Buffalo
Research output: Contribution to journal › Article › peer-review

Open Access
17 Scopus citations
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice
McKnight, D., Morales, A., Hatchell, K. E., Bristow, S. L., Bonkowsky, J. L., Perry, M. S., Berg, A. T., Borlot, F., Esplin, E. D., Moretz, C., Angione, K., Ríos-Pohl, L., Nussbaum, R. L., Aradhya, S., Haldeman-Englert, C. R., Levy, R. J., Parachuri, V. G., Lay-Son, G., De Montellano, D. J. D. O. & Ramirez-Garcia, M. A. & 105 others, Benítez Alonso, E. O., Ziobro, J., Chirita-Emandi, A., Felix, T. M., Kulasa-Luke, D., Megarbane, A., Karkare, S., Chagnon, S. L., Humberson, J. B., Assaf, M. J., Silva, S., Zarroli, K., Boyarchuk, O., Nelson, G. R., Palmquist, R., Hammond, K. C., Hwang, S. T., Boutlier, S. B., Nolan, M., Batley, K. Y., Chavda, D., Reyes-Silva, C. A., Miroshnikov, O., Zuccarelli, B., Amlie-Wolf, L., Wheless, J. W., Seinfeld, S., Kanhangad, M., Freeman, J. L., Monroy-Santoyo, S., Rodriguez-Vazquez, N., Ryan, M. M., MacHie, M., Guerra, P., Hassan, M. J., Candee, M. S., Bupp, C. P., Park, K. L., Muller, E., Lupo, P., Pedersen, R. C., Arain, A. M., Murphy, A., Schatz, K., Mu, W., Kalika, P. M., Plaza, L., Kellogg, M. A., Lora, E. G., Carson, R. P., Svystilnyk, V., Venegas, V., Luke, R. R., Jiang, H., Stetsenko, T., Dueñas-Roque, M. M., Trasmonte, J., Burke, R. J., Hurst, A. C. E., Smith, D. M., Massingham, L. J., Pisani, L., Costin, C. E., Ostrander, B., Filloux, F. M., Ananth, A. L., Mohamed, I. S., Nechai, A., Dao, J. M., Fahey, M. C., Aliu, E., Falchek, S., Press, C. A., Treat, L., Eschbach, K., Starks, A., Kammeyer, R., Bear, J. J., Jacobson, M., Chernuha, V., Meibos, B., Wong, K., Sweney, M. T., Espinoza, A. C., Van Orman, C. B., Weinstock, A., Kumar, A., Soler-Alfonso, C., Nolan, D. A., Raza, M., Rojas Carrion, M. D., Chari, G., Marsh, E. D., Shiloh-Malawsky, Y., Parikh, S., Gonzalez-Giraldo, E., Fulton, S., Sogawa, Y., Burns, K., Malets, M., Montiel Blanco, J. D., Habela, C. W., Wilson, C. A., Guzmán, G. G. & Pavliuk, M., Dec 12 2022, In: JAMA Neurology. 79, 12, p. 1267-1276 10 p.
University at Buffalo, SUNY Downstate Health Sciences University
Research output: Contribution to journal › Article › peer-review

Open Access
80 Scopus citations
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long-term open-label extension trial
Patel, A. D., Mazurkiewicz-Bełdzińska, M., Chin, R. F., Gil-Nagel, A., Gunning, B., Halford, J. J., Mitchell, W., Scott Perry, M., Thiele, E. A., Weinstock, A., Dunayevich, E., Checketts, D. & Devinsky, O., Sep 2021, In: Epilepsia. 62, 9, p. 2228-2239 12 p.
University at Buffalo
Research output: Contribution to journal › Article › peer-review

Open Access
100 Scopus citations
Clinical FDG-PET Findings in Patients with Temporal Lobe Epilepsy: Concordance with EEG and MRI
Jaisani, Z., Miletich, R. S., Ramanathan, M. & Weinstock, A. L., Jan 1 2020, In: Journal of Neuroimaging. 30, 1, p. 119-125 7 p.
University at Buffalo
Research output: Contribution to journal › Article › peer-review
14 Scopus citations

Arie Weinstock

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

GW EPiCog Study: An Open-label Exploratory Investigation of Cognitive Outcomes with Cannabidiol Oral Solution (EPIDlOLEX; GWP42003-P) (EPl-COG)

An Open Label extension study to investigate the safety of cannabidiol (GWP42002-P; CPD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes

A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome

Expanded access IND study

A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P; CBD) as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in children and adults

Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program

Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program

Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice

Long-term safety and efficacy of add-on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long-term open-label extension trial

Clinical FDG-PET Findings in Patients with Temporal Lobe Epilepsy: Concordance with EEG and MRI

Arie Weinstock

Fingerprint

Collaborations and top research areas from the last five years

Grants & Projects

Research output